Abstract
Madurella mycetomatis is the main cause of mycetoma, a chronic granulomatous infection for which currently no adequate therapy is available. To improve therapy, more knowledge on a molecular level is required to understand how M. mycetomatis is able to cause this disease. However, the genetic toolbox for M. mycetomatis is limited. To date, no method is available to genetically modify M. mycetomatis. In this paper, a protoplast-mediated transformation protocol was successfully developed for this fungal species, using hygromycin as a selection marker. Furthermore, using this method, a cytoplasmic-GFP-expressing M. mycetomatis strain was created. The reported methodology will be invaluable to explore the pathogenicity of M. mycetomatis and to develop reporter strains which can be useful in drug discovery as well as in genetic studies.
Funder
H2020 Marie Skłodowska-Curie Actions
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Erasmus Universiteit Rotterdam
Publisher
Public Library of Science (PLoS)
Reference20 articles.
1. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden;AOA Ahmed;Lancet Infec Dis,2004
2. Mycetoma: reviewing a neglected disease;P Verma;Clin Exp Dermatol,2019
3. Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae.;G Sheehan;PLoS Negl Trop Dis,2020
4. Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella;I Abugessaisa;bioRxiv,2022
5. Developing genetic tools to exploit Chaetomium thermophilum for biochemical analyses of eukaryotic macromolecular assemblies.;N Kellner;Sci Rep.,2016